Page last updated: 2024-10-30

losartan and Thyrotoxicosis

losartan has been researched along with Thyrotoxicosis in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.

Research Excerpts

ExcerptRelevanceReference
"Forty-four adult male Sprague-Dawley rats were divided into four groups: control group (saline), losartan group (10 mg/kg), thyrotoxicosis group (0."3.79Ang II receptor expression and effect of Ang II receptor blockade in thyrotoxic rat myocardium. ( Cao, YX; Ma, AQ; Wang, WF; Wang, XH, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, XH1
Wang, WF1
Cao, YX1
Ma, AQ1

Other Studies

1 other study available for losartan and Thyrotoxicosis

ArticleYear
Ang II receptor expression and effect of Ang II receptor blockade in thyrotoxic rat myocardium.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:19

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Losartan; Male; Myocardium; Peptidyl

2013